Blonder Tongue Laboratories Inc. (AMEX:BDR) currently has a daily average trading volume of 96.53K but it saw 94265554 shares traded on Wednesday. With a market cap of 13.41M USDstock’s current market price of $1.35 came rising about 77.61 while comparing to the previous closing price of $0.76. In past 52 weeks, the stock remained buoying in the range of price level as high as $1.10 and as low as $0.38. In the recent trading on the day, stock has struck highest price mark of $3.80 while lowest mark touched by it was $1.31.
Taking a look at 20-day trading activity of Blonder Tongue Laboratories Inc. (BDR) gives us an average price of $0.7937, while its current price level is 22.73% below from 52-week high level whereas it is 255.26% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.7505 while that of 200 days or SMA-200 reads an average of $0.6909. A closer look into the stock’s movement over the week reveals that its volatility is standing at 42.96% during that period while stretching the period over a month that decreases to 19.21%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 83.87 which implies that the stock is in overbought territory.
Over the week, BDR’s stock price is moving 73.08% up while it is 82.43% when we observe its performance for the past one month. Year-to-date it is 77.63% up and over the past year, the stock is showing an upside performance of 50.00%.
The company is expected to be releasing its next quarterly report in 11/17/2020, for which analysts forecasted an EPS of $0 while estimate for next year EPS is $0.
Currently, Blonder Tongue Laboratories Inc.’s total number of outstanding shares is 9.77M with 63.40% of that held by the insiders while 4.41% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -75.80%. Stock’s beta reads 0.25. Stock has a price to book (P/B) ratio of 3.07 while price to sale or P/S ratio amounts to 0.68.
A filing at the U.S. Securities and Exchange Commission revealed that Bridgeway Ultra Small Company Fun came shrinking its share ownership by 0.00% in the Blonder Tongue Laboratories Inc. (BDR) decreasing its stake to 3.01% with control over 0.0 shares in the company. As per SEC documents, Bridgeway Ultra Small Company Fun shunned 290,100 of company’s common stock of worth $0.21 million as per recent closing price of the stock. Bridgeway Ultra Small Company Fun is not the only institutional holder which restructured its stake in Blonder Tongue Laboratories Inc., as Bridgeway Ultra Small Company Mar dumped 20,000 shares of worth $14700.0 to bring its holdings to a total of 0.0 shares. In the most recent quarter, Vanguard Extended Market Index Fu came cutting its stake by 0.00% in the company and now holds 16400.0 or 0.17% of the company’s stake having worth of about 12054.0.